| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT06917911 Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment… |
Trial sites expanded: 7 -> 14 locations |
| 2026-06-12 | NCT05886049 A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and… |
Primary endpoint(s) modified |
| 2026-06-12 | NCT05886049 A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and… |
Enrollment increased: 28 -> 38 participants |
| 2026-06-04 | NCT07007312 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With… |
Trial sites expanded: 53 -> 71 locations |
| 2026-05-30 | NCT07052994 A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab… |
overall status: "Not Yet Recruiting" → "Withdrawn" |
| 2026-05-30 | NCT07052994 A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab… |
critical why stopped: null → "PI requested" |
| 2026-05-30 | NCT07052994 A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab… |
Enrollment reduced: 32 -> 0 participants |
| 2026-05-30 | NCT07052994 A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab… |
date change Primary completion moved earlier: 2032-12-31 -> 2026-05-21 |
| 2026-05-30 | NCT07052994 A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab… |
date change Completion moved earlier: 2034-12-31 -> 2026-05-21 |
| 2026-05-29 | NCT02883049 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B… |
Trial completed |
| 2026-05-29 | NCT02883049 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B… |
date change Completion moved earlier: 2026-10-03 -> 2026-03-31 |
| 2026-05-29 | NCT05157971 Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-29 | NCT05157971 Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell… |
date change Primary completion pushed: 2026-05-12 -> 2027-04-12 |
| 2026-05-29 | NCT05157971 Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell… |
date change Completion pushed: 2026-05-12 -> 2027-04-12 |
| 2026-05-23 | NCT06917911 Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment… |
Recruitment opened |
| 2026-05-23 | NCT06917911 Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment… |
Trial sites expanded: 0 -> 6 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-09 | NCT07636564 Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06289673 | Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute… | Acute Lymphoblastic Leukemia | Recruiting |
| Phase 3 | |||
| NCT06744504 | Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid… | AML | Recruiting |
| NCT03959085 | Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT04293562 | A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for… | Acute Myeloid Leukemia | Recruiting |
| NCT04043494 | International Cooperative Treatment Protocol for Children and Adolescents With… | Lymphoblastic Lymphoma, Childhood | Recruiting |
| NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT07007312 | Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With… | Acute Myeloid Leukemia (AML) | Recruiting |
| NCT03007147 | Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT02003222 | Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT02112916 | Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With… | Adult T Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| Phase 2/3 | |||
| NCT07072585 | Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With… | Stage II T Lymphoblastic Leukemia/Lymphoma | Not Yet Recruiting |
| NCT03701308 | Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients… | Acute Myeloid Leukemia | Active, Not Recruiting |
| NCT07255872 | A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax +… | Acute Myeloid Leukemia | Not Yet Recruiting |
| Phase 2 | |||
| NCT07228273 | Induction and Consolidation With Fludarabine, Cytarabine, Idarubicin, and Venetoclax for… | Acute Myeloid Leukemia | Recruiting |
| NCT06918431 | Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults… | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Recruiting |
| NCT06390319 | Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed… | T-cell Acute Lymphoblastic Leukemia | Recruiting |
| NCT06533748 | Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT06635681 | Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML | AML (Acute Myelogenous Leukemia) | Recruiting |
| NCT06124157 | A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT05554393 | Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax… | Acute Myeloid Leukemia | Recruiting |
| NCT05554406 | Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With… | Acute Myeloid Leukemia | Recruiting |
| NCT05564390 | MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study… | Acute Myeloid Leukemia | Recruiting |
| NCT06317662 | Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer… | Acute Leukemia of Ambiguous Lineage | Recruiting |
| NCT06917911 | Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment… | Core Binding Factor Acute Myeloid Leukemia | Recruiting |
| NCT02835222 | Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia… | Untreated Adult Acute Myeloid Leukemia | Active, Not Recruiting |